Liyang Zhang

Title: Innovations of Liyang Zhang in CRISPR Technology

Introduction

Liyang Zhang is a prominent inventor based in Coralville, IA (US), known for his significant contributions to the field of genetic engineering. He holds a total of four patents, showcasing his innovative work in CRISPR technology and DNA manipulation.

Latest Patents

Among his latest patents, Liyang Zhang has developed Cas12a mutants with enhanced cleavage activity at non-canonical TTTT protospacer adjacent motifs. This invention describes CAS12A mutants derived from Lachnospiraceae bacterium, which exhibit improved DNA cleavage activities compared to the wild-type enzyme. Another notable patent involves mutations in Cas9 discovered through broad scanning mutagenesis, which enhance DNA cleavage activity. This invention focuses on mutant Cas9 nucleic acids and proteins for use in CRISPR/Cas endonuclease systems, highlighting an isolated mutant Cas9 protein that demonstrates increased on-target editing activity relative to the wild-type system.

Career Highlights

Liyang Zhang is currently employed at Integrated DNA Technologies, Inc., where he continues to advance research in genetic engineering. His work has been pivotal in enhancing the capabilities of CRISPR technology, making it more efficient and effective for various applications.

Collaborations

He collaborates with notable colleagues, including Christopher Anthony Vakulskas and Nathaniel Hunter Roberts, contributing to a dynamic research environment that fosters innovation.

Conclusion

Liyang Zhang's contributions to the field of CRISPR technology through his patents and collaborative efforts underscore his role as a leading inventor in genetic engineering. His work continues to pave the way for advancements in this critical area of research.